ZUG, Switzerland and NEW YORK, Nov. 11, 2015 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a development-stage biopharmaceutical company focused on innovative products to treat cancers and central nervous system (CNS) diseases, today announced that it has appointed to its Scientific Advisory Board ("SAB") Larry W. Kwak, MD, PhD, of the City of Hope National Medical Center, and Jedd D. Wolchok, MD, PhD, of Memorial Sloan Kettering Cancer Center (MSK). Drs. Kwak and Wolchok join existing members of SELLAS's SAB, including: David A. Scheinberg, MD, PhD, of MSK; Prof. Agamemnon A. Epenetos, MB, ChB, PhD, FRCP, of Trojantec Limited; Sattva Neelapu, MD, PhD, of the University of Texas...
↧